Prevention, Cure And Interception Vital ForJanssen Cardiometabolic R&D
Executive Summary
With readouts in trials of key drugs Invokana and Xarelto coming, Dr. James F. List of Janssen is also looking for assets designed to prevent, cure or even intercept the progression of key diseases such as obesity and NASH.